Applying insights from biofilm biology to drug development — can a new approach be developed?
暂无分享,去创建一个
Thomas Bjarnsholt | Søren Molin | S. Molin | N. Høiby | M. Givskov | T. Bjarnsholt | Michael Givskov | Niels Høiby | O. Ciofu | Oana Ciofu
[1] Thomas Bjarnsholt,et al. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. , 2005, Microbiology.
[2] M. Hamilton,et al. Measuring antimicrobial effects on biofilm bacteria: from laboratory to field. , 1999, Methods in enzymology.
[3] S. Ankri,et al. Antimicrobial properties of allicin from garlic. , 1999, Microbes and infection.
[4] L. Rasmussen,et al. Infection Risk with Nitrofurazone-Impregnated Urinary Catheters in Trauma Patients , 2007, Annals of Internal Medicine.
[5] Thomas Bjarnsholt,et al. Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. , 2010, FEMS immunology and medical microbiology.
[6] Kathrine B. Christensen,et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. , 2005, Microbiology.
[7] D. Pompliano,et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.
[8] N. Bagge,et al. Antibodies against β‐lactamase can improve ceftazidime treatment of lung infection with β‐lactam‐resistant Pseudomonas aeruginosa in a rat model of chronic lung infection , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[9] Angela Lee,et al. MexXY-OprM Efflux Pump Is Necessary for Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides , 2003, Antimicrobial Agents and Chemotherapy.
[10] J. Costerton,et al. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters , 1984, Journal of clinical microbiology.
[11] B. Christensen,et al. Molecular tools for study of biofilm physiology. , 1999, Methods in enzymology.
[12] S. de Bentzmann,et al. Hacking into bacterial biofilms: a new therapeutic challenge , 2011, Annals of intensive care.
[13] D. Tifrea,et al. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Hassett,et al. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. , 2002, Advanced drug delivery reviews.
[15] J. Hahn,et al. Tolerance of dormant and active cells in Pseudomonas aeruginosa PA01 biofilm to antimicrobial agents. , 2009, The Journal of antimicrobial chemotherapy.
[16] Y. Hirakata,et al. Azithromycin Exhibits Bactericidal Effects on Pseudomonas aeruginosa through Interaction with the Outer Membrane , 2005, Antimicrobial Agents and Chemotherapy.
[17] C. Sternberg,et al. An in vitro model of bacterial infections in wounds and other soft tissues , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[18] C. Meisner,et al. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients , 2007, Proceedings of the National Academy of Sciences.
[19] N. Høiby,et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients , 2009, Pediatric pulmonology.
[20] P. Stewart,et al. Gene expression and protein levels of the stationary phase sigma factor, RpoS, in continuously-fed Pseudomonas aeruginosa biofilms. , 2001, FEMS microbiology letters.
[21] D. Hassett,et al. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. , 2006, The Journal of clinical investigation.
[22] R. Darouiche,et al. New strategies to prevent catheter-associated urinary tract infections , 2012, Nature Reviews Urology.
[23] Thomas Bjarnsholt,et al. Quorum Sensing Antagonism from Marine Organisms , 2007, Marine Biotechnology.
[24] S. Lory,et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen , 2000, Nature.
[25] A. Ojha,et al. Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms , 2012, Expert review of anti-infective therapy.
[26] H. Kristensen,et al. Effects of Intratracheal Administration of Novispirin G10 on a Rat Model of Mucoid Pseudomonas aeruginosa Lung Infection , 2005, Antimicrobial Agents and Chemotherapy.
[27] J. Costerton,et al. Microbial Biofilms , 2011 .
[28] J. Costerton,et al. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy , 1992, Antimicrobial Agents and Chemotherapy.
[29] C. van Delden,et al. Swarming of Pseudomonas aeruginosa Is Dependent on Cell-to-Cell Signaling and Requires Flagella and Pili , 2000, Journal of bacteriology.
[30] G. Jackson,et al. Pathogenicity of staphylococci; a comparison of alpha-hemolysin production with the coagulase test and clinical observations of virulence. , 1955, The New England journal of medicine.
[31] D. Maki,et al. Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] Roberto Kolter,et al. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis , 1998, Molecular microbiology.
[33] Federica Villa,et al. Effects of Photoactivated Titanium Dioxide Nanopowders and Coating on Planktonic and Biofilm Growth of Pseudomonas aeruginosa , 2011, Photochemistry and Photobiology.
[34] S. Molin,et al. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants , 2003, Molecular microbiology.
[35] Peilin Wu,et al. Preliminary Observations , 1830, The Medico-chirurgical review.
[36] J. Carlet,et al. Quorum sensing-dependent virulence during Pseudomonas aeruginosa colonisation and pneumonia in mechanically ventilated patients , 2010, Thorax.
[37] J. Costerton,et al. Bacterial biofilms: a common cause of persistent infections. , 1999, Science.
[38] S. M. Kirov,et al. Iron chelation directed against biofilms as an adjunct to conventional antibiotics. , 2009, American journal of physiology. Lung cellular and molecular physiology.
[39] O. Ciofu,et al. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[40] A. Larsson,et al. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients , 2008, Pediatric pulmonology.
[41] L. Eberl,et al. Screening for Quorum-Sensing Inhibitors (QSI) by Use of a Novel Genetic System, the QSI Selector , 2005, Journal of bacteriology.
[42] E. Greenberg,et al. Influence of Quorum Sensing and Iron on Twitching Motility and Biofilm Formation in Pseudomonas aeruginosa , 2007, Journal of bacteriology.
[43] S. Molin,et al. In Situ Growth Rates and Biofilm Development of Pseudomonas aeruginosa Populations in Chronic Lung Infections , 2007, Journal of bacteriology.
[44] J. Collins,et al. Heterogeneous Bacterial Persisters and Engineering Approaches to Eliminate Them This Review Comes from a Themed Issue on Genomics Edited More than One Way to Make a Persister Persisters and Physiological Heterogeneity Engineering Treatments for Persisters , 2022 .
[45] Forest Rohwer,et al. Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals , 2009, PloS one.
[46] A. Grant,et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial , 2012, The Lancet.
[47] S. Kjelleberg,et al. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling , 1996, Journal of bacteriology.
[48] M. Enright,et al. The role of regulated clinical trials in the development of bacteriophage therapeutics , 2012, Journal of molecular and genetic medicine : an international journal of biomedical research.
[49] A. Birch‐Andersen,et al. Morphology Of Pseudomonas aeruginosa phages from the sputum of cystic fibrosis patients and from the phage typing set , 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[50] Howard C. Berg,et al. Genetic analysis , 1957, Nature Biotechnology.
[51] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] H. Whitfield,et al. Prophylactic efficacy of a new gentamicin‐releasing urethral catheter in short‐term catheterized rabbits , 2001, BJU International.
[53] S. Molin,et al. Phenotypes of Non-Attached Pseudomonas aeruginosa Aggregates Resemble Surface Attached Biofilm , 2011, PloS one.
[54] J. Costerton,et al. Bacterial biofilms in nature and disease. , 1987, Annual review of microbiology.
[55] Hans-Curt Flemming,et al. The EPS Matrix: The “House of Biofilm Cells” , 2007, Journal of bacteriology.
[56] Efficacy of the lithotripsy in treating lower pole renal stones , 2013, Urolithiasis.
[57] Martin Schuster,et al. Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production , 2004, Antimicrobial Agents and Chemotherapy.
[58] H. Brüssow. Pseudomonas Biofilms, Cystic Fibrosis, and Phage: a Silver Lining? , 2012, mBio.
[59] P. Williams,et al. The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling. , 2011, Environmental microbiology.
[60] P. Shaw,et al. Role of hydrochloric acid in the treatment of central venous catheter infections in children with cancer , 2004, Cancer.
[61] G. Pugliese,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Infection Control & Hospital Epidemiology.
[62] P. Stewart,et al. Arginine or Nitrate Enhances Antibiotic Susceptibility of Pseudomonas aeruginosa in Biofilms , 2006, Antimicrobial Agents and Chemotherapy.
[63] E. Greenberg,et al. Iron and Pseudomonas aeruginosa biofilm formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[64] Søren Molin,et al. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms , 2003, Molecular microbiology.
[65] J. Costerton,et al. Antibiotic resistance of bacteria in biofilms , 2001, The Lancet.
[66] P. Gilligan,et al. Microbiology of airway disease in patients with cystic fibrosis , 1991, Clinical Microbiology Reviews.
[67] T. Tolker-Nielsen,et al. Proteins with GGDEF and EAL domains regulate Pseudomonas putida biofilm formation and dispersal. , 2006, FEMS microbiology letters.
[68] A. Beauvais,et al. Aspergillus fumigatus biofilms in the clinical setting. , 2011, Medical mycology.
[69] K. Poole. Bacterial stress responses as determinants of antimicrobial resistance. , 2012, The Journal of antimicrobial chemotherapy.
[70] M. Givskov,et al. The immune system vs. Pseudomonas aeruginosa biofilms. , 2010, FEMS immunology and medical microbiology.
[71] L. Herzenberg,et al. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[72] S. Sørensen,et al. The interconnection between biofilm formation and horizontal gene transfer. , 2012, FEMS immunology and medical microbiology.
[73] T. Coenye,et al. Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model , 2012 .
[74] J. Martínez. The role of natural environments in the evolution of resistance traits in pathogenic bacteria , 2009, Proceedings of the Royal Society B: Biological Sciences.
[75] J. Faoagali,et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: Results from a prospective trial , 2008, Scandinavian journal of infectious diseases.
[76] K. M. Lee,et al. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[77] S. Assinder,et al. Mathematical model of β-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released β-lactamases , 1996 .
[78] S. Kjelleberg,et al. Cell Death in Pseudomonas aeruginosa Biofilm Development , 2003, Journal of bacteriology.
[79] S. Lewenza,et al. Extracellular DNA Chelates Cations and Induces Antibiotic Resistance in Pseudomonas aeruginosa Biofilms , 2008, PLoS pathogens.
[80] S. Molin,et al. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. , 2001, Microbiology.
[81] K. Mathee,et al. Panax ginseng has anti-infective activity against opportunistic pathogen Pseudomonas aeruginosa by inhibiting quorum sensing, a bacterial communication process critical for establishing infection. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[82] P. Stewart,et al. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance , 2003, Nature.
[83] Hsin-Chieh Yeh,et al. Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. , 2013, JAMA internal medicine.
[84] G. Weinstock,et al. Effects of Enterococcus faecalis fsrGenes on Production of Gelatinase and a Serine Protease and Virulence , 2000, Infection and Immunity.
[85] N. Raffaelli,et al. Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors , 2009, Applied Microbiology and Biotechnology.
[86] Frank Cerny. From laboratory to the “field” , 1996, Pediatric pulmonology.
[87] Krasimir Vasilev,et al. Antibacterial surfaces for biomedical devices , 2009, Expert review of medical devices.
[88] D. Touw,et al. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[89] P. Stewart. New ways to stop biofilm infections , 2003, The Lancet.
[90] P. Stewart,et al. Theoretical aspects of antibiotic diffusion into microbial biofilms , 1996, Antimicrobial agents and chemotherapy.
[91] J. Collins,et al. A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.
[92] D. Davies,et al. A Fatty Acid Messenger Is Responsible for Inducing Dispersion in Microbial Biofilms , 2008, Journal of bacteriology.
[93] A. Weinberg,et al. Antimicrobial activity of gentamicin palmitate against high concentrations of Staphylococcus aureus , 2011, Journal of materials science. Materials in medicine.
[94] N. Schiller,et al. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms , 2006, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[95] S. Dye,et al. An evolutionary perspective of the knee. , 1987, The Journal of bone and joint surgery. American volume.
[96] Valeria Souza,et al. Stress-Induced Mutagenesis in Bacteria , 2003, Science.
[97] S. Molin,et al. Heterogeneity of Biofilms Formed by Nonmucoid Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis , 2005, Journal of Clinical Microbiology.
[98] Chengping Lu,et al. Application of a Bacteriophage Lysin To Disrupt Biofilms Formed by the Animal Pathogen Streptococcus suis , 2011, Applied and Environmental Microbiology.
[99] H. Kristensen,et al. Plectasin Shows Intracellular Activity against Staphylococcus aureus in Human THP-1 Monocytes and in a Mouse Peritonitis Model , 2009, Antimicrobial Agents and Chemotherapy.
[100] G. Volckaert,et al. Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials , 2009, PloS one.
[101] M. Jadoul,et al. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[102] Michael J. MacCoss,et al. Aminoglycoside antibiotics induce bacterial biofilm formation , 2005, Nature.
[103] Qun Ma,et al. Engineering a novel c-di-GMP-binding protein for biofilm dispersal. , 2011, Environmental microbiology.
[104] P Stoodley,et al. Survival strategies of infectious biofilms. , 2005, Trends in microbiology.
[105] I. Chopra,et al. Increased mutability of Pseudomonas aeruginosa in biofilms. , 2008, The Journal of antimicrobial chemotherapy.
[106] B. Iglewski,et al. Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation , 2004, Journal of Clinical Microbiology.
[107] P. Williams,et al. Controlling infection by tuning in and turning down the volume of bacterial small-talk. , 2002, The Lancet. Infectious diseases.
[108] T. Tolker-Nielsen,et al. The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms. , 2012, FEMS immunology and medical microbiology.
[109] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[110] N. Høiby,et al. Avidity of anti-P aeruginosaantibodies during chronic infection in patients with cystic fibrosis , 1999, Thorax.
[111] L. J. Douglas,et al. Effects of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs on Biofilms and Planktonic Cells of Candida albicans , 2004, Antimicrobial Agents and Chemotherapy.
[112] I. Chopra,et al. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections , 2010, Nature Reviews Microbiology.
[113] C. Desnues,et al. Bacteriophages as vehicles of the resistome in cystic fibrosis. , 2011, The Journal of antimicrobial chemotherapy.
[114] N. Høiby,et al. Interactions between Polymorphonuclear Leukocytes and Pseudomonas aeruginosa Biofilms on Silicone Implants In Vivo , 2012, Infection and Immunity.
[115] T. Mah,et al. Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics , 2008, Journal of bacteriology.
[116] D. Kadouri,et al. Growing and Analyzing Static Biofilms , 2006, Current protocols in microbiology.
[117] N. Chauhan,et al. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A , 2012, Annals of Clinical Microbiology and Antimicrobials.
[118] Weiling Fu,et al. Bacteriophage Cocktail for the Prevention of Biofilm Formation by Pseudomonas aeruginosa on Catheters in an In Vitro Model System , 2009, Antimicrobial Agents and Chemotherapy.
[119] G. Pier,et al. Inactivation of the rhlA gene in Pseudomonas aeruginosa prevents rhamnolipid production, disabling the protection against polymorphonuclear leukocytes , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[120] Mirian Domenech,et al. In Vitro Destruction of Streptococcus pneumoniae Biofilms with Bacterial and Phage Peptidoglycan Hydrolases , 2011, Antimicrobial Agents and Chemotherapy.
[121] M. Shirtliff,et al. Resolution of Staphylococcus aureus Biofilm Infection Using Vaccination and Antibiotic Treatment , 2011, Infection and Immunity.
[122] G. Anderson,et al. Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis , 2012, European Respiratory Journal.
[123] M. Maciá,et al. Dynamics of Mutator and Antibiotic-Resistant Populations in a Pharmacokinetic/Pharmacodynamic Model of Pseudomonas aeruginosa Biofilm Treatment , 2011, Antimicrobial Agents and Chemotherapy.
[124] A. Filloux,et al. Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. , 2011, Environmental microbiology.
[125] Leo Eberl,et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. , 2002, Microbiology.
[126] Kwang-tae Choi,et al. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer , 2008, Acta Pharmacologica Sinica.
[127] Philip S. Stewart,et al. Contributions of Antibiotic Penetration, Oxygen Limitation, and Low Metabolic Activity to Tolerance of Pseudomonas aeruginosa Biofilms to Ciprofloxacin and Tobramycin , 2003, Antimicrobial Agents and Chemotherapy.
[128] Garth D Ehrlich,et al. Physiology of Pseudomonas aeruginosa in biofilms as revealed by transcriptome analysis , 2010, BMC Microbiology.
[129] N. Høiby,et al. Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms , 2011, Antimicrobial Agents and Chemotherapy.
[130] R. Morton,et al. Therapeutic ultrasound as treatment for chronic rhinosinusitis: preliminary observations. , 2010, The Journal of laryngology and otology.
[131] P. Williams,et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. , 2007, Microbiology.
[132] J. Vleugels,et al. The nonsteroidal antiinflammatory drug diclofenac potentiates the in vivo activity of caspofungin against Candida albicans biofilms. , 2012, The Journal of infectious diseases.
[133] K. Sauer,et al. SagS Contributes to the Motile-Sessile Switch and Acts in Concert with BfiSR To Enable Pseudomonas aeruginosa Biofilm Formation , 2011, Journal of bacteriology.
[134] D. Maki,et al. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[135] T. Bjarnsholt,et al. A UVC Device for Intra‐luminal Disinfection of Catheters: In Vitro Tests on Soft Polymer Tubes Contaminated with Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli and Candida albicans , 2011, Photochemistry and photobiology.
[136] D. McDougald,et al. Pseudomonas aeruginosa PAO1 Preferentially Grows as Aggregates in Liquid Batch Cultures and Disperses upon Starvation , 2009, PloS one.
[137] Blaise R. Boles,et al. Endogenous oxidative stress produces diversity and adaptability in biofilm communities , 2008, Proceedings of the National Academy of Sciences.
[138] Viktoria Hancock,et al. Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation , 2008, Applied and Environmental Microbiology.
[139] R. Kobza,et al. Bacterial Colonization and Infection of Electrophysiological Cardiac Devices Detected With Sonication and Swab Culture , 2010, Circulation.
[140] L. Zeef,et al. Characterization of Nutrient-Induced Dispersion in Pseudomonas aeruginosa PAO1 Biofilm , 2004, Journal of bacteriology.
[141] P. Stewart,et al. Role of Antibiotic Penetration Limitation in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin , 2000, Antimicrobial Agents and Chemotherapy.
[142] Lindsey A. Lorenz,et al. A method for growing a biofilm under low shear at the air–liquid interface using the drip flow biofilm reactor , 2009, Nature Protocols.
[143] Anders Folkesson,et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective , 2012, Nature Reviews Microbiology.
[144] N. Høiby,et al. Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation , 2005, Antimicrobial Agents and Chemotherapy.
[145] C. von Buchwald,et al. Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[146] F. Malouin,et al. Iron transport-mediated drug delivery using mixed-ligand siderophore-beta-lactam conjugates. , 1996, Chemistry & biology.
[147] M. Parsek,et al. Bacterial biofilms: an emerging link to disease pathogenesis. , 2003, Annual review of microbiology.
[148] T. Wilt,et al. Systematic Review: Antimicrobial Urinary Catheters To Prevent Catheter-Associated Urinary Tract Infection in Hospitalized Patients , 2006, Annals of Internal Medicine.
[149] B. Marquez. Bacterial efflux systems and efflux pumps inhibitors. , 2005, Biochimie.
[150] Philip S. Stewart,et al. Stratified Growth in Pseudomonas aeruginosa Biofilms , 2004, Applied and Environmental Microbiology.
[151] N. Høiby,et al. PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS , 2009 .
[152] Thomas Bjarnsholt,et al. Quorum sensing inhibitory drugs as next generation antimicrobials: Worth the effort? , 2008, Current infectious disease reports.
[153] J. Costerton,et al. Observations of fouling biofilm formation. , 1981, Canadian journal of microbiology.
[154] I. Sutherland,et al. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. , 1998, Microbiology.
[155] A. Gristina,et al. Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.
[156] C. Potera. Studying slime. , 1998, Environmental health perspectives.
[157] J. Alder,et al. Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells , 2007, Antimicrobial Agents and Chemotherapy.
[158] L. Eberl,et al. Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation , 2005 .
[159] H. Budzikiewicz. Siderophore-antibiotic conjugates used as trojan horses against Pseudomonas aeruginosa. , 2001, Current topics in medicinal chemistry.
[160] K. Krogfelt,et al. Why chronic wounds will not heal: a novel hypothesis , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[161] A. Gristina. Biomaterial-centered infection: microbial adhesion versus tissue integration. 1987. , 2004, Clinical orthopaedics and related research.
[162] M. Hentzer,et al. Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr−/− Mice , 2007, Antimicrobial Agents and Chemotherapy.
[163] N. Høiby,et al. Effect of aerosolized rhDNase (Pulmozyme®) on pulmonary colonization in patients with cystic fibrosis , 2006, Acta paediatrica.
[164] O. Ciofu. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. , 2003, APMIS. Supplementum.
[165] S. Molin,et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. , 2010, The Journal of infectious diseases.
[166] K. Marchal,et al. The small regulatory RNA molecule MicA is involved in Salmonella enterica serovar Typhimurium biofilm formation , 2010, BMC Microbiology.
[167] F. D. De Rosa,et al. Early experience with high-dosage daptomycin for prosthetic infections. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[168] P. Stewart,et al. Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics , 1997, Antimicrobial agents and chemotherapy.
[169] T. B. Rasmussen,et al. Quorum-sensing inhibitors as anti-pathogenic drugs. , 2006, International journal of medical microbiology : IJMM.
[170] R. Darouiche,et al. Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.
[171] N. Høiby,et al. Antibodies against Pseudomonas aeruginosa chromosomal β-lactamase in patients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to β-lactams , 1995 .
[172] Chih-kuan Tung,et al. Acceleration of Emergence of Bacterial Antibiotic Resistance in Connected Microenvironments , 2011, Science.
[173] K. Lewis,et al. Persister cells. , 2010, Annual review of microbiology.
[174] S. Molin,et al. Synergistic Activities of an Efflux Pump Inhibitor and Iron Chelators against Pseudomonas aeruginosa Growth and Biofilm Formation , 2010, Antimicrobial Agents and Chemotherapy.
[175] Garth D. Ehrlich,et al. Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms , 2004, Antimicrobial Agents and Chemotherapy.
[176] S. Kjelleberg,et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors , 2003, The EMBO journal.
[177] M. Cuéllar-Cruz,et al. Candida species: new insights into biofilm formation. , 2012, Future microbiology.
[178] R. Darouiche,et al. Antibacterial activity of antibiotic coated silicone grafts. , 1998, The Journal of urology.
[179] L. Eberl,et al. Ajoene, a Sulfur-Rich Molecule from Garlic, Inhibits Genes Controlled by Quorum Sensing , 2012, Antimicrobial Agents and Chemotherapy.
[180] A. Grossman,et al. Biochemical and genetic characterization of a competence pheromone from B. subtilis , 1994, Cell.
[181] M. Parsek,et al. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. , 2009, Microbiology.
[182] Leo Eberl,et al. Surface Motility of Serratia liquefaciens MG1 , 1999, Journal of bacteriology.
[183] Paul Stoodley,et al. Bacterial biofilms: from the Natural environment to infectious diseases , 2004, Nature Reviews Microbiology.
[184] J W Costerton,et al. How bacteria stick. , 1978, Scientific American.
[185] M. Hentzer,et al. Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms , 2004, Antimicrobial Agents and Chemotherapy.
[186] H. Ceri,et al. The Calgary Biofilm Device: New Technology for Rapid Determination of Antibiotic Susceptibilities of Bacterial Biofilms , 1999, Journal of Clinical Microbiology.
[187] A. Chakraborty. Electron Microscopy Study , 2014 .
[188] T. Tolker-Nielsen,et al. Insight into the microbial multicellular lifestyle via flow‐cell technology and confocal microscopy , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[189] Bonnie L. Bassler,et al. Quorum-sensing regulators control virulence gene expression in Vibrio cholerae , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[190] Frederick M. Ausubel,et al. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation , 2002, Nature.
[191] S. Molin,et al. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. , 2004, The Journal of antimicrobial chemotherapy.
[192] Blaise R. Boles,et al. agr-Mediated Dispersal of Staphylococcus aureus Biofilms , 2008, PLoS pathogens.
[193] Bonnie L Bassler,et al. Chemical communication among bacteria , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[194] L. Fernández,et al. Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance , 2013, Clinical Microbiology Reviews.
[195] T. Tolker-Nielsen,et al. The implication of Pseudomonas aeruginosa biofilms in infections. , 2011, Inflammation & allergy drug targets.
[196] Stefan Wuertz,et al. High Rates of Conjugation in Bacterial Biofilms as Determined by Quantitative In Situ Analysis , 1999, Applied and Environmental Microbiology.
[197] S. Molin,et al. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[198] R. Samudrala,et al. Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix , 2010, Molecular microbiology.
[199] D. Haas,et al. The ArgR Regulatory Protein, a Helper to the Anaerobic Regulator ANR during Transcriptional Activation of thearcD Promoter in Pseudomonas aeruginosa , 1999, Journal of bacteriology.
[200] M. Leunig,et al. Improved Diagnosis of Periprosthetic Joint Infection by Multiplex PCR of Sonication Fluid from Removed Implants , 2010, Journal of Clinical Microbiology.
[201] A. Filloux,et al. Two-component regulatory systems in Pseudomonas aeruginosa: an intricate network mediating fimbrial and efflux pump gene expression , 2011, Molecular microbiology.
[202] N. Høiby,et al. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. , 2010, Microbiology.
[203] A. Dominguez,et al. The role of diclofenac sodium in the dimorphic transition in Candida albicans. , 2010, Microbial pathogenesis.
[204] A. Gristina. Microbial Adhesion versus Tissue Integration , 2004 .
[205] J. Oliver,et al. Recent findings on the viable but nonculturable state in pathogenic bacteria. , 2010, FEMS microbiology reviews.
[206] L. Touqui,et al. Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention , 2011, PloS one.
[207] M. Hentzer,et al. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. , 2003, The Journal of clinical investigation.
[208] Christophe Pichon,et al. Small RNA gene identification and mRNA target predictions in bacteria , 2008, Bioinform..
[209] H. Buchholz,et al. [Experimental and clinical studies on the release of gentamicin from bone cement]. , 1972, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[210] M. Givskov,et al. In vitro screens for quorum sensing inhibitors and in vivo confirmation of their effect , 2010, Nature Protocols.
[211] Thomas Bjarnsholt,et al. Towards diagnostic guidelines for biofilm-associated infections. , 2012, FEMS immunology and medical microbiology.
[212] D. Hassett,et al. Involvement of Nitric Oxide in Biofilm Dispersal of Pseudomonas aeruginosa , 2006, Journal of bacteriology.
[213] T. Tolker-Nielsen,et al. Quorum Sensing and Virulence of Pseudomonas aeruginosa during Lung Infection of Cystic Fibrosis Patients , 2010, PloS one.
[214] C. Hill,et al. Bacteriophages ϕMR299-2 and ϕNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells , 2012, mBio.
[215] N. Høiby. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. , 1977, Acta pathologica et microbiologica Scandinavica. Supplement.
[216] L. Jacobsen,et al. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. , 1977, Scandinavian journal of respiratory diseases.
[217] A. Oliver,et al. High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms , 2012, Antimicrobial Agents and Chemotherapy.
[218] N. Høiby,et al. Biological Trojan Horse: Antigen 43 Provides Specific Bacterial Uptake and Survival in Human Neutrophils , 2006, Infection and Immunity.
[219] H. Schweizer,et al. Molecular Basis of Azithromycin-Resistant Pseudomonas aeruginosa Biofilms , 2005, Antimicrobial Agents and Chemotherapy.
[220] M. Rohde,et al. Pseudomonas aeruginosa cupA‐encoded fimbriae expression is regulated by a GGDEF and EAL domain‐dependent modulation of the intracellular level of cyclic diguanylate , 2007 .
[221] N. Høiby,et al. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[222] Liang Yang,et al. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. , 2011, FEMS immunology and medical microbiology.
[223] L. J. Douglas,et al. Prostaglandin production during growth of Candida albicans biofilms. , 2005, Journal of medical microbiology.
[224] G. O’Toole,et al. Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. , 2009, American journal of respiratory cell and molecular biology.
[225] S. Molin,et al. Involvement of N‐acyl‐l‐homoserine lactone autoinducers in controlling the multicellular behaviour of Serratia liquefaciens , 1996, Molecular microbiology.
[226] Abdelwahab Omri,et al. Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. , 2009, The Journal of antimicrobial chemotherapy.
[227] T. Tolker-Nielsen,et al. Detection of Bacteria by Fluorescence in Situ Hybridization in Culture‐Negative Soft Tissue Filler Lesions , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[228] E. Greenberg,et al. Chelator-Induced Dispersal and Killing of Pseudomonas aeruginosa Cells in a Biofilm , 2006, Applied and Environmental Microbiology.
[229] T. Bauer,et al. Brief Ultrasonication Improves Detection of Biofilm-formative Bacteria Around a Metal Implant , 2006, Clinical orthopaedics and related research.
[230] J. Aronson,et al. What is a clinical trial? , 2004, British journal of clinical pharmacology.
[231] T. Tolker-Nielsen,et al. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB‐oprM genes , 2008, Molecular microbiology.
[232] T. Tolker-Nielsen,et al. Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa , 2008, Antimicrobial Agents and Chemotherapy.
[233] A. Marchese,et al. Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. , 2008, International journal of antimicrobial agents.
[234] A. Baccarelli,et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial , 2008, Intensive Care Medicine.
[235] L. Sampath,et al. Evaluation of the Antimicrobial Efficacy of Urinary Catheters Impregnated With Antiseptics in an In Vitro Urinary Tract Model , 2003, Infection Control & Hospital Epidemiology.
[236] D. Warren,et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[237] T. Tolker-Nielsen,et al. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control , 2010, Expert Reviews in Molecular Medicine.
[238] L. Saiman. The use of macrolide antibiotics in patients with cystic fibrosis , 2004, Current opinion in pulmonary medicine.
[239] T. Tolker-Nielsen,et al. Distribution, Organization, and Ecology of Bacteria in Chronic Wounds , 2008, Journal of Clinical Microbiology.
[240] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[241] E. Greenberg,et al. The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent , 2008, Proceedings of the National Academy of Sciences.
[242] Pradeep K. Singh,et al. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. , 2007, The Journal of clinical investigation.
[243] S. Molin,et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. , 2005, Microbiology.
[244] E. Änggård,et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[245] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[246] E. Witsø,et al. Sonication is superior to scraping for retrieval of bacteria in biofilm on titanium and steel surfaces in vitro , 2009, Acta orthopaedica.
[247] M. Elkins,et al. Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions , 2005, Journal of Clinical Microbiology.
[248] M. Sugai,et al. Effect of the Growth Rate of Pseudomonas aeruginosa Biofilms on the Susceptibility to Antimicrobial Agents: β-Lactams and Fluoroquinolones , 1999, Chemotherapy.
[249] S. Molin,et al. Mutations in 23S rRNA Confer Resistance against Azithromycin in Pseudomonas aeruginosa , 2012, Antimicrobial Agents and Chemotherapy.